Cargando…

Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study

BACKGROUND: The IP1-PROSTAGRAM study showed that a short, non-contrast MRI detected more significant cancers with similar rates of biopsy compared to PSA. Herein, we compare the expected and perceived burden of PSA, MRI and ultrasound as screening tests. METHODS: IP1-PROSTAGRAM was a prospective, po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eldred-Evans, David, Winkler, Mathias, Klimowska-Nassar, Natalia, Burak, Paula, Connor, Martin J., Fiorentino, Francesca, Day, Emily, Price, Derek, Gammon, Martin, Tam, Henry, Sokhi, Heminder, Padhani, Anwar R., Ahmed, Hashim U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449626/ https://www.ncbi.nlm.nih.gov/pubmed/37002379 http://dx.doi.org/10.1038/s41391-023-00662-6

Ejemplares similares

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study
por: Eldred-Evans, David, et al.
Publicado: (2021)

Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM study
por: Day, Emily, et al.
Publicado: (2022)

PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study
por: Bass, E.J., et al.
Publicado: (2021)

Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study
por: Day, Emily, et al.
Publicado: (2021)

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection
por: Pchejetski, Dmitri, et al.
Publicado: (2023)

Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
por: Eldred-Evans, David, et al.
Publicado: (2020)

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial
por: Connor, Martin John, et al.
Publicado: (2021)

Identifying men affected by changes in PSA screening in the COVID-19 pandemic
por: Bass, E.J., et al.
Publicado: (2022)

Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study
por: Connor, Martin John, et al.
Publicado: (2021)

Prostate imaging features that indicate benign or malignant pathology on biopsy
por: Lovegrove, Catherine Elizabeth, et al.
Publicado: (2018)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach
por: Miah, Saiful, et al.
Publicado: (2019)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

PET imaging of tumour hypoxia
por: Padhani, Anwar
Publicado: (2006)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Where are we with imaging oxygenation in human tumours?
por: Padhani, Anwar R
Publicado: (2005)

Whole-body MRI and diffusion MRI
por: Padhani, Anwar R
Publicado: (2014)

MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014)

High acceptability, convenience and reduced carbon emissions of tele-neurology outpatient services at a regional referral centre in Kenya
por: Yakub, Fazal Abdulaziz, et al.
Publicado: (2023)

The role of PSA density in the MRI pathway for prostate cancer diagnostics
por: Cash, Hannes, et al.
Publicado: (2022)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Clustering of IP(3) receptors by IP(3) retunes their regulation by IP(3) and Ca(2+)
por: Taufiq-Ur-Rahman,, et al.
Publicado: (2009)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Correction to: The role of PSA density in the MRI pathway for prostate cancer diagnostics
por: Cash, Hannes, et al.
Publicado: (2023)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
por: McGagh, Dylan, et al.
Publicado: (2020)

The Acceptability of Food Policies
por: Espinosa, Romain, et al.
Publicado: (2021)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

PSA 1972 : proceedings of the 1972 biennial meeting philosophy of science association
Publicado: (1974)

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer
por: Khoo, Christopher C., et al.
Publicado: (2020)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
por: Tang, Qionghua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jpolfeqnesriik11nmpg6nbse2